These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5458907)

  • 1. [Ulcero-hemorrhagic rectocolitis, Crohn's disease and sulpiride].
    Toulet J; Rousselet J
    Therapeutique; 1970 Oct; 46(8):763-75. PubMed ID: 5458907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ulcero-hemorrhagic rectocolitis, Crohn's disease and sulpiride].
    Toulet J; Rousselet J
    Sem Hop; 1970 Jun; 46(29):Suppl:41-53. PubMed ID: 4316827
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent results of azathioprine treatment in hemorrhagic rectocolitis and colonic Crohn's disease].
    Vachon MA; Barthe TJ; Kressmann P; Piante M
    Arch Fr Mal App Dig; 1972 Oct; 61(11):625-40. PubMed ID: 4634205
    [No Abstract]   [Full Text] [Related]  

  • 4. [Failure of disodium cromoglycate in the treatment of 17 patients with chronic inflammatory diseases of the intestine. An occasion to review the pathogenetic problems of ulcerative rectocolitis and Crohn's disease].
    Franchi F; Meneghelli M; Seminara P; Spadini M; Bonomo R
    Minerva Dietol Gastroenterol; 1982; 28(4):285-91. PubMed ID: 6820127
    [No Abstract]   [Full Text] [Related]  

  • 5. [Round table on the relations among ulcero-hemorrhagic rectocolitis, Crohn's disease and granulomatous colitis].
    Le Quintrec Y; Maratka Z; Mialaret J; Morson BC; Potet F
    Actual Hepatogastroenterol (Paris); 1968; 4(5):A287-303. PubMed ID: 5721706
    [No Abstract]   [Full Text] [Related]  

  • 6. [New therapeutic trials of sulpiride].
    Félix H
    Sem Hop; 1970 Jun; 46(29):Suppl:15-22. PubMed ID: 4317663
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current focus on inflammatory intestinal diseases: Crohn's disease and ulcero-hemorrhagic rectocolitis].
    Fontaine F; Brassinne A; Delforge M; Demoulin JC; Drèze C; Gillard V; Bastens B
    Rev Med Liege; 1993 Nov; 48(11):593-618. PubMed ID: 7904768
    [No Abstract]   [Full Text] [Related]  

  • 8. [Idiopathic ulcerative colitis and ileocolitis: relation to Crohn's disease and hemorrhagic rectocolitis].
    Vachon A; Guillemin G; Paliard P; Gauthier J; Tete R; Cuilleret J; Spay G; Guillaud ; Maillet P; Cuche J
    J Med Lyon; 1968 Jul; 49(146):1177-200. PubMed ID: 5687751
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ulcero-hemorrhagic rectocolitis, Crohn's disease and granulomatous colitis (elements of differential diagnosis)].
    Lambling A
    Cah Coll Med Hop Paris; 1969 Jun; 10(8):701-3. PubMed ID: 5400567
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of the natural product propolis on ulcerative colitis and Crohn's disease].
    Danø P; Møller EH; Jarnum S
    Ugeskr Laeger; 1979 Jul; 141(28):1888-90. PubMed ID: 473408
    [No Abstract]   [Full Text] [Related]  

  • 11. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic alternatives in Crohn disease and in ulcero-hemorrhagic rectocolitis: current findings].
    Louis E; Belaiche J; Delwaide J; Gast P
    Rev Med Liege; 1992 Nov; 47(11):573-8. PubMed ID: 1462064
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ulcero-hemorrhagic rectocolitis and ulcerative colitis. Clinical forms].
    Parturier-Albot M
    Actual Hepatogastroenterol (Paris); 1968; 4(2):A107-30. PubMed ID: 5688645
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
    Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
    Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
    Ho GT; Chiam P; Drummond H; Loane J; Arnott ID; Satsangi J
    Aliment Pharmacol Ther; 2006 Jul; 24(2):319-30. PubMed ID: 16842459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of ulcerative colitis and Crohn's disease.
    Rhodes JM
    J Clin Hosp Pharm; 1983 Sep; 8(3):219-32. PubMed ID: 6138368
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hereditary incidence of Crohn's disease and hemorrhagic rectocolitis: 3 familial cases].
    Monges A; Legré M; Rampal M; Tronconi JC; Boucher J
    Arch Fr Mal App Dig; 1968 Jun; 57(4):514-5. PubMed ID: 5741158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.